Literature DB >> 33862829

Superspreading events suggest aerosol transmission of SARS-CoV-2 by accumulation in enclosed spaces.

John M Kolinski1, Tobias M Schneider1.   

Abstract

Viral transmission pathways have profound implications for public safety; it is thus imperative to establish a complete understanding of viable infectious avenues. Mounting evidence suggests SARS-CoV-2 can be transmitted via the air; however, this has not yet been demonstrated. Here we quantitatively analyze virion accumulation by accounting for aerosolized virion emission and destabilization. Reported superspreading events analyzed within this framework point towards aerosol mediated transmission of SARS-CoV-2. Virion exposure calculated for these events is found to trace out a single value, suggesting a universal minimum infective dose (MID) via aerosol that is comparable to the MIDs measured for other respiratory viruses; thus, the consistent infectious exposure levels and their commensurability to known aerosol-MIDs establishes the plausibility of aerosol transmission of SARS-CoV-2. Using filtration at a rate exceeding the destabilization rate of aerosolized SARS-CoV-2 can reduce exposure below this infective dose.

Entities:  

Year:  2021        PMID: 33862829     DOI: 10.1103/PhysRevE.103.033109

Source DB:  PubMed          Journal:  Phys Rev E        ISSN: 2470-0045            Impact factor:   2.529


  3 in total

1.  Quantifying the COVID19 infection risk due to droplet/aerosol inhalation.

Authors:  Rahul Bale; Akiyoshi Iida; Masashi Yamakawa; ChungGang Li; Makoto Tsubokura
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

2.  Finding the infectious dose for COVID-19 by applying an airborne-transmission model to superspreader events.

Authors:  Mara Prentiss; Arthur Chu; Karl K Berggren
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

3.  Prevalence of SARS-CoV-2 RNA on inanimate surfaces: a systematic review and meta-analysis.

Authors:  Simone Belluco; Marzia Mancin; Filippo Marzoli; Alessio Bortolami; Eva Mazzetto; Alessandra Pezzuto; Michela Favretti; Calogero Terregino; Francesco Bonfante; Roberto Piro
Journal:  Eur J Epidemiol       Date:  2021-07-27       Impact factor: 12.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.